SVB Leerink analyst Puneet Souda maintains Bruker (NASDAQ:BRKR) with a Outperform and raises the price target from $84 to $85.
Oppenheimer Maintains Outperform on Medtronic, Raises Price Target to $147
Oppenheimer analyst Steven Lichtman maintains Medtronic (NYSE:MDT) with a Outperform and raises the price target from $134 to $147.